AHRQ releases health risk appraisal report draft
The Agency for Healthcare Research and Quality (AHRQ) has made available for public comment a draft of its technology assessment report for health risk appraisal (HRA).
The AHRQ’s Technology Assessment (TA) Program develops systematic reviews, health technology assessments and other reports at the request of the Centers for Medicare & Medicaid Services (CMS) Coverage and Analysis Group.
Prepared by the McMaster University Evidence-based Practice Center for the CMS, the primary goals of the assessment were to describe key features of HRAs, examine which features were associated with successful HRAs, and discuss the applicability of HRAs to the Medicare population.
CMS, in consultation with the Practice Center and the AHRQ, drafted the following key questions to guide the technology assessment:
1. Describe the characteristics of the provision of HRAs, including the following:
3. What is the generalizability of the data in Questions 1 and 2 to the Medicare population or subpopulations?
Funded by an interagency agreement from CMS to AHRQ, this report will be used to inform national coverage policies, discussion at public Medicare Evidence Development and Coverage Advisory Committee meetings and/or for other policy considerations.
Comments are due by 5p.m. EST February 9. Access the draft here.
The AHRQ’s Technology Assessment (TA) Program develops systematic reviews, health technology assessments and other reports at the request of the Centers for Medicare & Medicaid Services (CMS) Coverage and Analysis Group.
Prepared by the McMaster University Evidence-based Practice Center for the CMS, the primary goals of the assessment were to describe key features of HRAs, examine which features were associated with successful HRAs, and discuss the applicability of HRAs to the Medicare population.
CMS, in consultation with the Practice Center and the AHRQ, drafted the following key questions to guide the technology assessment:
1. Describe the characteristics of the provision of HRAs, including the following:
- Which specific HRAs were studied in the literature?
- What were the methods of HRA administration, e.g., telephone, web-based, in the doctor‘s office, community based, workplace based, or other?
- What was the training of personnel who administered HRAs?
- What were the methods and frequencies of followup?
- What were the characteristics of the patient populations who received HRAs?
3. What is the generalizability of the data in Questions 1 and 2 to the Medicare population or subpopulations?
Funded by an interagency agreement from CMS to AHRQ, this report will be used to inform national coverage policies, discussion at public Medicare Evidence Development and Coverage Advisory Committee meetings and/or for other policy considerations.
Comments are due by 5p.m. EST February 9. Access the draft here.